A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.
about
Clinical management of achalasia: current state of the artPharmacotherapy for the management of achalasia: Current status, challenges and future directionsIdiopathic (primary) achalasia: a reviewNew insights into the pathophysiology of achalasia and implications for future treatmentManagement of primary achalasia: The role of endoscopyA controversy that has been tough to swallow: is the treatment of achalasia now digested?Achalasia: current therapeutic optionsAchalasia: a new clinically relevant classification by high-resolution manometryAchalasia - an update.Review article: the management of achalasia - a comparison of different treatment modalities.Idiopathic (primary) achalasia.Peroral endoscopic myotomy for treatment of achalasia: initial results of a korean study.Self-expandable metal stents for achalasia: Thinking out of the box!Review article: botulinum toxin in the therapy of gastrointestinal motility disorders.Effect of peroral esophageal myotomy for achalasia treatment: A Chinese study.Contraction of abdominal wall muscles influences size and occurrence of incisional hernia.Treatment of achalasia in the era of high-resolution manometry.High-resolution manometric subtypes as a predictive factor for the treatment of achalasia: A meta-analysis and systematic review.Systematic review and meta-analysis: Efficacy and safety of POEM for achalasia.Safety and efficacy of botulinum toxin injection therapy for esophageal achalasia in JapanEndoscopic treatment of esophageal achalasia.Botulinum toxin for gastrointestinal disorders: therapy and mechanisms.Endoscopic approach to achalasia.Update on the management of achalasia: balloons, surgery and drugs.Recurrent achalasia treated with Heller myotomy: a review of the literatureBotulinum Toxin Injection for Treatment of Chronic Anal Fissure: Is There Any Dose-Dependent Efficiency? A Meta-Analysis.Impact of minimally invasive surgery in the spectrum of current achalasia treatment options.Achalasia--a disease of unknown cause that is often diagnosed too late.ACG clinical guideline: diagnosis and management of achalasia.Advances in the treatment of achalasia.Management strategies for achalasia.An update on the use of botulinum toxin therapy in Parkinson's disease.Treatment of gastrointestinal sphincters spasms with botulinum toxin A.Treatments for achalasia in 2017: how to choose among them.Managing Esophageal Dysphagia in the Elderly.Complications of botulinum toxin injections for treatment of esophageal motility disorders†.Management of achalasia.An Overview of Achalasia and Its Subtypes.Ethanolamine oleate versus botulinum toxin in the treatment of idiopathic achalasia.Achalasia: a review of Western and Iranian experiences.
P2860
Q26750707-F6FF3548-68B0-48AE-96EC-B446463004B2Q26777632-55FDB814-0002-458F-B680-64BE369C76AFQ26801313-38B339C9-8C19-49D3-A2CE-C71BDCD1AB86Q28068914-F9188ED5-E7A2-459C-AE3A-872C7D5615FEQ28083770-B96D34D5-AD17-402D-8324-CCB99030CAA7Q33672723-9C30EDC4-5BC3-40D0-A03E-0F5D8B8CBD2BQ33887695-15564B11-3019-4740-96CA-F94B2BE83DE7Q33952505-331FAE5C-A86A-4D0E-9326-600454EAB188Q34028403-364F2F05-A6F0-42BD-89A2-6AD0A4F6EF30Q34562734-AE83ACAD-C198-4561-A9CA-9A3A4CF8F4EEQ34583301-DEA36D47-3DD5-4081-AE3B-B8EC1C0DA748Q34650847-8AC9CAB6-04F8-4FBA-8552-28769358D34CQ34966746-C854A623-E340-409D-87B9-D8BC09634420Q35171808-ED81C081-2418-47F9-B361-BD6EEE431FDEQ35594266-4E2EB093-70FB-4279-AD04-7331FC50A46DQ35756118-78632DBE-700E-4980-AEEE-0C12BEB15FF8Q35779468-761C5C23-6A3B-4E21-AAFC-5D0A12581C9BQ35918812-95897EFF-DBF3-4AAD-8B0D-C71C04E69FE5Q35926103-AA397957-C2ED-4A2A-ABB0-D3001DA087F9Q36265364-23EC69F5-5888-4666-9DF3-84F14EB43C59Q36493448-9EAC3991-C4E3-4B29-8D85-B02422E9CD60Q36511599-6FFB4232-C88A-4442-BA25-4E028AA205A8Q37093306-D4F4E484-39B7-4850-BDD4-76A69DDF3CECQ37345954-D11C8D30-1ECA-4CE4-A434-5038408DF8C3Q37351508-171EA3D6-3E69-4F99-A09D-EB254DA38634Q37408038-F09FDDFF-D34A-4EBD-B366-85D7BD011816Q37898860-8D5DCCD3-3D77-4025-9F36-57C530C0862BQ38005376-1D42FAF4-CC75-41A1-89DB-83F52C8636BAQ38123364-A620FFE0-0F61-477C-97D6-583DBDD840A8Q38176298-E3AF7BF0-7AA6-4B34-A7A2-E7F9D3436C25Q38244263-8654C203-DA8C-4ED1-886D-698A1974CF21Q38269292-1610F01F-0284-4610-9164-F9E3FFCE4127Q38512950-5154FB2B-8AE8-4207-8D4D-62B460B6B708Q38828675-9D24CBEF-303F-4847-B385-603DAB9832C8Q38899094-27B82A70-C528-42C5-9BE2-37C0AA90EFAAQ39170924-563BEB37-9ECE-4EEE-9D02-FBAA95C9CB1EQ39736933-6BCBFD9A-D3F5-4D0F-B3A5-F47B0D3211FCQ41531364-C19872B2-CD3F-4D0B-8B1D-116D20796206Q41832017-C023BE73-D86E-488A-931B-E79C00E88D6CQ42594366-22BDF4E4-6732-4BF8-A709-DBFE8A365871
P2860
A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. GISMAD Achalasia Study Group.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@ast
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@en
type
label
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@ast
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@en
prefLabel
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@ast
A multicentre randomised study ...... GISMAD Achalasia Study Group.
@en
P2093
P2860
P356
P1433
P1476
A multicentre randomised study ...... . GISMAD Achalasia Study Group
@en
P2093
G Bassotti
P A Testoni
V D'Onofrio
P2860
P304
P356
10.1136/GUT.46.5.597
P407
P577
2000-05-01T00:00:00Z